2025 Clinic Degenerative Disc Disease 
OrthoSpineNews
JUNE 18, 2025
BALTIMORE, June 18, 2025 -( BUSINESS WIRE )- ReGelTec Inc. , study follows the company’s receipt of CE Mark for the HYDRAFIL System based on promising results of clinical studies performed outside the United States on 75 patients. The launch of the HYDRAFIL-D U.S. Walnut Creek, Calif.; Greenwood Village, Colo.; Jasper, Ga.;
OrthoSpineNews
APRIL 1, 2025
Optimizing the fixation process with Neos Force Control Technology supports real improvements in clinical outcomes and patients’ quality of life. About the Study The clinical study involved 75 patients undergoing thoracolumbar fusion surgery to treat conditions including trauma, spinal stenosis, and degenerative disc disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
OrthoSpineNews
JULY 10, 2025
IDE clinical trial. OREM, Utah, July 10, 2025 /PRNewswire/ — Dymicron ® , a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) spine centers, with the first implantations expected in Q4 2025. The trial will enroll patients across several leading U.S.
OrthoSpineNews
MAY 13, 2025
May 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. Food and Drug Association (FDA) is requiring at least a greater than 30% improvement in both Oswestry Disability Index (ODI) and Visual Analog Scale (VAS ); ongoing clinical data demonstrates trends greater than 30% improvements in both measures. MELVILLE, N.Y.,
OrthoSpineNews
MARCH 3, 2025
Frank Phillips Joins SST Board of Directors SAN ANTONIO, March 3, 2025 /PRNewswire/ — Spinal Stabilization Technologies, LLC (SST) has announced a significant milestone in its mission to revolutionize spinal care: the enrollment of the first U.S. “This is an exciting time for SST as we expand our clinical research into the U.S.
OrthoSpineNews
JUNE 25, 2025
First in the Nation to Perform Custom Combination of prodisc® C Nova and prodisc® C VIVO Disc Replacement. June 25, 2025 /PRNewswire/ — VSI® proudly announces a groundbreaking achievement in spine surgery, led by nationally recognized spine surgeon Dr. Ehsan Jazini. RESTON, Va.,
OrthoSpineNews
JULY 29, 2025
Data readout expected in Q1 2026 MIAMI, July 29, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, Inc., We are pleased to announce the completion of enrollment in our ASCEND trial ahead of schedule, a key milestone in the continued development of VIA Disc NP,” said Barry Salzman, Co-President and Chief Operating Officer of Vivex.
Expert insights. Personalized for you.
Let's personalize your content